These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29861847)

  • 1. Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells.
    Vangapandu HV; Alston B; Morse J; Ayres ML; Wierda WG; Keating MJ; Marszalek JR; Gandhi V
    Oncotarget; 2018 May; 9(38):24980-24991. PubMed ID: 29861847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells.
    Vangapandu HV; Ayres ML; Bristow CA; Wierda WG; Keating MJ; Balakrishnan K; Stellrecht CM; Gandhi V
    Neoplasia; 2017 Oct; 19(10):762-771. PubMed ID: 28863345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation.
    Liu F; Kalpage HA; Wang D; Edwards H; Hüttemann M; Ma J; Su Y; Carter J; Li X; Polin L; Kushner J; Dzinic SH; White K; Wang G; Taub JW; Ge Y
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia.
    Vangapandu HV; Havranek O; Ayres ML; Kaipparettu BA; Balakrishnan K; Wierda WG; Keating MJ; Davis RE; Stellrecht CM; Gandhi V
    Mol Cancer Res; 2017 Dec; 15(12):1692-1703. PubMed ID: 28835371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas.
    de Groot E; Varghese S; Tan L; Knighton B; Sobieski M; Nguyen N; Park YS; Powell R; Lorenzi PL; Zheng B; Stephan C; Gopal YNV
    Cancer Metab; 2022 Feb; 10(1):6. PubMed ID: 35193687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inhibitor of oxidative phosphorylation exploits cancer vulnerability.
    Molina JR; Sun Y; Protopopova M; Gera S; Bandi M; Bristow C; McAfoos T; Morlacchi P; Ackroyd J; Agip AA; Al-Atrash G; Asara J; Bardenhagen J; Carrillo CC; Carroll C; Chang E; Ciurea S; Cross JB; Czako B; Deem A; Daver N; de Groot JF; Dong JW; Feng N; Gao G; Gay J; Do MG; Greer J; Giuliani V; Han J; Han L; Henry VK; Hirst J; Huang S; Jiang Y; Kang Z; Khor T; Konoplev S; Lin YH; Liu G; Lodi A; Lofton T; Ma H; Mahendra M; Matre P; Mullinax R; Peoples M; Petrocchi A; Rodriguez-Canale J; Serreli R; Shi T; Smith M; Tabe Y; Theroff J; Tiziani S; Xu Q; Zhang Q; Muller F; DePinho RA; Toniatti C; Draetta GF; Heffernan TP; Konopleva M; Jones P; Di Francesco ME; Marszalek JR
    Nat Med; 2018 Jul; 24(7):1036-1046. PubMed ID: 29892070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
    Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
    Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS-010759.
    Pujalte-Martin M; Belaïd A; Bost S; Kahi M; Peraldi P; Rouleau M; Mazure NM; Bost F
    Mol Oncol; 2024 Jul; 18(7):1719-1738. PubMed ID: 38214418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to Dasatinib in primary chronic lymphocytic leukemia lymphocytes involves AMPK-mediated energetic re-programming.
    Martinez Marignac VL; Smith S; Toban N; Bazile M; Aloyz R
    Oncotarget; 2013 Dec; 4(12):2550-66. PubMed ID: 24334291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of CLL cells by venetoclax treatment reverses oxidative stress and impaired glycolysis in CD4 T cells.
    van Bruggen JAC; van der Windt GJW; Hoogendoorn M; Dubois J; Kater AP; Peters FS
    Blood Adv; 2022 Jul; 6(14):4185-4195. PubMed ID: 35580333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the autophagy in bone marrow stromal cells overcomes resistance to vorinostat in chronic lymphocytic leukemia.
    Ding L; Zhang W; Yang L; Pelicano H; Zhou K; Yin R; Huang R; Zeng J
    Onco Targets Ther; 2018; 11():5151-5170. PubMed ID: 30210236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous mitochondrial transfer and endogenous mitochondrial fission facilitate AML resistance to OxPhos inhibition.
    Saito K; Zhang Q; Yang H; Yamatani K; Ai T; Ruvolo V; Baran N; Cai T; Ma H; Jacamo R; Kuruvilla V; Imoto J; Kinjo S; Ikeo K; Moriya K; Suzuki K; Miida T; Kim YM; Vellano CP; Andreeff M; Marszalek JR; Tabe Y; Konopleva M
    Blood Adv; 2021 Oct; 5(20):4233-4255. PubMed ID: 34507353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Metabolic Vulnerabilities to Overcome Prostate Cancer Resistance: Dual Therapy with Apalutamide and Complex I Inhibition.
    Baumgartner V; Schaer D; Eberli D; Salemi S
    Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma.
    Vashisht Gopal YN; Gammon S; Prasad R; Knighton B; Pisaneschi F; Roszik J; Feng N; Johnson S; Pramanik S; Sudderth J; Sui D; Hudgens C; Fischer GM; Deng W; Reuben A; Peng W; Wang J; McQuade JL; Tetzlaff MT; Di Francesco ME; Marszalek J; Piwnica-Worms D; DeBerardinis RJ; Davies MA
    Clin Cancer Res; 2019 Nov; 25(21):6429-6442. PubMed ID: 31439581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [
    Gammon ST; Pisaneschi F; Bandi ML; Smith MG; Sun Y; Rao Y; Muller F; Wong F; De Groot J; Ackroyd J; Mawlawi O; Davies MA; Gopal YNV; Di Francesco ME; Marszalek JR; Dewhirst M; Piwnica-Worms D
    Cells; 2019 Nov; 8(12):. PubMed ID: 31766580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCO2 Mediates Oxidative Stress-Induced Glycolysis to Oxidative Phosphorylation Switch in Hematopoietic Stem Cells.
    Du W; Amarachintha S; Wilson AF; Pang Q
    Stem Cells; 2016 Apr; 34(4):960-71. PubMed ID: 26676373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose metabolism and metabolic flexibility in blood platelets.
    Aibibula M; Naseem KM; Sturmey RG
    J Thromb Haemost; 2018 Nov; 16(11):2300-2314. PubMed ID: 30151891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells.
    Cervantes-Gomez F; Stellrecht CM; Ayres ML; Keating MJ; Wierda WG; Gandhi V
    Oncotarget; 2019 Apr; 10(29):2793-2809. PubMed ID: 31073371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition.
    Mirabilii S; Piedimonte M; Conte E; Mirabilii D; Rossi FM; Bomben R; Zucchetto A; Gattei V; Tafuri A; Ricciardi MR
    Curr Issues Mol Biol; 2024 May; 46(6):5085-5099. PubMed ID: 38920977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype and Site Specific-Induced Metabolic Vulnerabilities in Prostate Cancer.
    Mossa F; Robesti D; Sumankalai R; Corey E; Titus M; Kang Y; Zhang J; Briganti A; Montorsi F; Vellano CP; Marszalek JR; Frigo DE; Logothetis CJ; Gujral TS; Dondossola E
    Mol Cancer Res; 2023 Jan; 21(1):51-61. PubMed ID: 36112348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.